Amarin Corp plc (ADR) (NASDAQ:AMRN)
CAPS Rating:
The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders.
Get rich slowly
The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Cost-effectiveness of amr101. Underappreciated patent protection based on proprietary manufacturing techniques.